FAAH mRNA expression in colonic biopsies from patients with IBS-D and IBS-C <i>vs.</i> healthy controls.

<p>The results are shown as mean ± SEM.</p

PEA levels in plasma from IBS patients.

<div><p>PEA levels in plasma 0, 30, 60 and 120 min after blood sample collection from IBS-D (A) and IBS-C (B) patients vs. abdominal cramping frequency.</p> <p>The results are shown as mean ± SEM of n=7 for each group. Each sample was run in triplicate.</p></div

Endocannabinoid (anandamide, AEA; 2-arachidonoyl glycerol, 2-AG) and cannabinoid-like fatty acid amide (<i>N</i>-oleoyl ethanolamine, OEA; <i>N-</i>palmitoyl ethanolamine, PEA) levels in plasma 0, 30, 60 and 120 min after blood sample collection from IBS-D and IBS-C patients vs.

<div><p><b>healthy controls</b>. </p> <p>The results are shown as mean ± SEM of n=7 for each group. Each sample was run in triplicate.</p></div